| Literature DB >> 18830420 |
Chae Ha Yang1, Bong Hyo Lee, Sung Hoon Sohn.
Abstract
Clinical trials are currently underway to determine the effectiveness of acupuncture in the treatment of drug addiction. While there are still many unanswered questions about the basic mechanisms of acupuncture, some evidence exists to suggest that acupuncture can play an important role in reducing reinforcing effects of abused drugs. The purpose of this article is to critically review these data. The neurochemical and behavioral evidence showed that acupuncture's role in suppressing the reinforcing effects of abused drugs takes place by modulating mesolimbic dopamine neurons. Also, several brain neurotransmitter systems such as serotonin, opioid and amino acids including GABA have been implicated in the modulation of dopamine release by acupuncture. These results provided clear evidence for the biological effects of acupuncture that ultimately may help us to understand how acupuncture can be used to treat abused drugs. Additional research using animal models is of primary importance to understanding the basic mechanism underlying acupuncture's effectiveness in the treatment of drug addiction.Entities:
Keywords: acupoint; drug abuse; mesolimbic dopamine system; opioid reward system
Year: 2008 PMID: 18830420 PMCID: PMC2529396 DOI: 10.1093/ecam/nem081
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1.A hypothetical model of possible bidirectional effects of acupuncture on dopamine release in the nucleus accumbens. In positive reinforcement, acupuncture treatment activates GABAB receptors on the dopamine cell bodies, resulting in a decrease of dopamine release in the nucleus accumbens through the inhibition of dopaminergic neurons; additionally, acupuncture activates presynaptic κ-opioid receptors in the nucleus accumbens through dynorphin neurons, resulting in a decrease of dopamine release in the nucleus accumbens. In negative reinforcement, acupuncture treatment stimulates enkephalin neurons in the hypothalamus, such that methionine-enkephalin released in the VTA interacts with μ-opioid receptors to inhibit VTA GABAergic interneurons, inducing the disinhibition of dopaminergic neurons and thus, eventually increases the dopamine release in the nucleus accumbens.